1- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran 2- Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran , A_bolhasani@pasteur.ac.ir 3- Department of Hematology and Oncology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran
Abstract: (671 Views)
Background: Von Willebrand disease (VWD) is the most common inherited bleeding disorder around the world. Large size of the gene and heterogeneous nature of its mutations, make it difficult to determine the exact nature of mutations in VWD. Some missense mutations are common in VWD and can be assessed as first step of determining the genetic cause of the disease. Materials and methods: Forty four unrelated patients categorized as VWD type 3 were included in study. Tetra ARMS-PCR was applied to determine the presence of the point mutations rs61753984 and rs62643623. Then ARMS-PCR was performed with the same primers. In cases with mutant patterns, Sanger sequencing was used for conformation of results. Results: Two patients showed two bands of 248bp and 181bp in rs61753984 (R34X), which corresponds to homozygous mutant genotype. In other patients, homozygous pattern with 248bp and121bp bands was observed. In rs62643623 (Q218X) position, one patient with two bands of 378bp and 260bp showed homozygous mutant genotype while other patients showed homozygous wild genotype (378bp and 168bp bands). The results of ARMS-PCR was the same as tetra ARMS-PCR. Finally, the results of tetra ARMS-PCR were confirmed by Sanger sequencing. Conclusion: In present study we used tetra ARMS-PCR for detection of point mutations, while in most studies PCR-PFLP has been used. We found that tetra ARMS-PCR can be used as a simple, cost effective and reliable method. If these mutations are not found, advanced molecular methods such as sequencing should be applied.
1. Weyand AC, Flood VH. Von Willebrand Disease: Current Status of Diagnosis and Management. Hematol Oncol Clin North Am. 2021;35:1085-101.
2. Eladly F, Miesbach W. Von Willebrand Disease-Specific Aspects in Women. Hamostaseologie 2022;42:330-6.
https://doi.org/10.1055/a-1891-9976
3. Dorgalaleh A, Tabibian S, Shams M, Ala F, Bahoush G, Jazebi M, et al. Von Willebrand disease in Iran: diagnosis and management. Ann blood 2018;3:1-11.
https://doi.org/10.21037/aob.2018.01.01
4. Fogarty H, Doherty D, O'Donnell JS. New developments in von Willebrand disease. Br J Haematol 2020;191:329-39.
https://doi.org/10.1111/bjh.16681
5. Von Willebrand EA. Hereditary pseudohaemophilia. Haemophilia 1999;5:223-31.
https://doi.org/10.1046/j.1365-2516.1999.00302.x
6. Sharma R, Haberichter SL. New advances in the diagnosis of von Willebrand disease. Hematology Am Soc Hematol Educ Program 2019;2019:596-600.
https://doi.org/10.1182/hematology.2019000064
7. Goodeve A, James P. von Willebrand Disease. 2009 Jun 4 [updated 2017 Oct 5]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023.
8. Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med 2016;375:2067-80.
https://doi.org/10.1056/NEJMra1601561
9. Echahdi H, El Hasbaoui B, El Khorassani M, Agadr A, Khattab M. Von Willebrand's disease: case report and review of literature. Pan Afr Med J 2017;27:147.
https://doi.org/10.11604/pamj.2017.27.147.12248
10. The World Federation of Hemophilia (WFH). Report on the Annual Global Survey 2021. Available from: https://wfh.org/article/report-on-the-annual-global-survey-2021-now-available/
11. Kujovich JL. von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management. Am J Hematol 2005;79:220-8.
https://doi.org/10.1002/ajh.20372
12. Mansouritorghabeh H. Consanguineous marriage and rare bleeding disorders. Expert Rev Hematol 2021;14:467-72.
https://doi.org/10.1080/17474086.2021.1923476
13. Saadat M, Zarghami M. Consanguineous marriages among Iranian Mandaeans living in south-west Iran. J Biosoc Sci 2018;50:451-6.
https://doi.org/10.1017/S0021932017000207
14. Payandeh M, Rahimi Z, Kansestani AN, Hemmati S, Aleyasin M, Zare ME, et al. Clinical features and types of von Willebrand disease in women with menorrhagia referred to hematology clinic of kermanshah. Int J Hematol Oncol Stem Cell Res 2013;7:1-5.
15. Rahbar N, Faranoush M, Ghorbani R, Sadr Alsadat B. Screening of von Willebrand disease in Iranian women with menorrhagia. Iran Red Crescent Med J 2015;17:e18244.
https://doi.org/10.5812/ircmj.18244
16. Gindele R, Kerényi A, Kállai J, Pfliegler G, Schlammadinger Á, Szegedi I, et al. Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing. Life (Basel) 2021;11.
https://doi.org/10.3390/life11030202
17. Favaloro EJ, Pasalic L. Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives. Semin Thromb Hemost 2022;48:750-66.
https://doi.org/10.1055/s-0042-1754331
18. Kasatkar P, Shetty S, Ghosh K. VWF pseudogene: Mimics, masks and spoils. Clin Chim Acta 2010; 411: 607-609.
https://doi.org/10.1016/j.cca.2009.12.024
19. Shahbazi S, Mahdian R, Ala F, LAVERGNE JM, Denis C, Christophe O. Molecular characterization of Iranian patients with type 3 von Willebrand disease. Haemophilia 2009;15:1058-64.
https://doi.org/10.1111/j.1365-2516.2009.02046.x
20. Baronciani L, Cozzi G, Canciani MT, Peyvandi F, Srivastava A, Federici AB, et al. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003;30:264-70.
https://doi.org/10.1016/S1079-9796(03)00033-0
21. Etlik O, Koksal V, Arican-Baris ST, Baris I. Development and validation of a cost-effective in-house method, tetra-primer ARMS PCR assay, in genotyping of seven clinically important point mutations. Mol Cell Probes 2011;25:177-81.
https://doi.org/10.1016/j.mcp.2011.04.005
22. Undi R, Lim HY, Wang W. Rapid and reliable identification of insulin 2 gene mutation in Akita diabetic mice by a tetra-primer-ARMS-PCR method. Heliyon 2019;5:e01112.
https://doi.org/10.1016/j.heliyon.2018.e01112
23. Suhda S, Paramita DK, Fachiroh J. Tetra primer ARMS PCR optimization to detect single nucleotide polymorphisms of the CYP2E1 gene. Asian Pacific J Cancer Prev 2016;17:3065-9.
24. Medrano RFV, De Oliveira CA. Guidelines for the tetra-primer ARMS-PCR technique development. Mol Biotechnol 2014;56:599-608.
https://doi.org/10.1007/s12033-014-9734-4
25. Wang Y, Chen H, Wei H, Rong Z, Wang S. Tetra-primer ARMS-PCR combined with dual-color fluorescent lateral flow assay for the discrimination of SARS-CoV-2 and its mutations with a handheld wireless reader. Lab Chip 2022;22:1531-41.
https://doi.org/10.1039/D1LC01167G
26. Zongze Z, Xin Y, Awais AA, Weiqiang L, Chunqun W, Di W, et al. Development of a tetra-primer ARMS-PCR for detecting the E198A SNP in the isotype-1 β-tubulin gene of Haemonchus contortus populations in China. Vet Parasitol 2018;252:127-30.
https://doi.org/10.1016/j.vetpar.2018.01.021
27. Muhammad SB, Hassan F, Bhowmik KK, Millat MS, Sarwar MS, Aziz MA, et al. Detection of association of IL1β, IL4R, and IL6 gene polymorphisms with cervical cancer in the Bangladeshi women by tetra-primer ARMS-PCR method. Int Immunopharmacol 2021;90:107131.
https://doi.org/10.1016/j.intimp.2020.107131
28. Mahmoudi S, Badali H, Rezaie S, Azarnezhad A, Barac A, Kord M, et al. A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus. Mol Biol Rep 2019;46:4537-43.
https://doi.org/10.1007/s11033-019-04909-1
29. Heidari MM, Hadadzadeh M, Fallahzadeh H. Development of One-Step Tetra-primer ARMS-PCR for Simultaneous Detection of the Angiotensin Converting Enzyme (ACE) I/D and rs4343 Gene Polymorphisms and the Correlation with CAD Patients. Avicenna J Med Biotechnol 2019;11:118-23.
30. Fatima S, Khan B, Khan OY, Amjad M, Zehra S, Azhar A. Tetra-primers ARMS-PCR Based Association Analyses of Synonymous and Intronic Variants in the ADAM12 Gene with Susceptibility to Knee Osteoarthritis: A Case-Control Study. Biochem Genet 2022;60:1695-715.
https://doi.org/10.1007/s10528-022-10189-5 [DOI:10.1016/j.hoc.2021.07.004]
Khatib M, Bolhassani , A, Noormohammadi Z, Ghazizadeh M. Genotyping rs61753984 (R34X) and rs62643623 (Q218X) in Von Willebrand disease patients by tetra ARMS-PCR. MEDICAL SCIENCES 2023; 33 (2) :174-182 URL: http://tmuj.iautmu.ac.ir/article-1-2075-en.html